Nanotechnology for Intracerebral Hemorrhage: Advances, Opportunities, and Potential for Clinical Translation
ACS Nano Medicine · 11.11.2026 · 1 (10) · 2540-2568
DOI: 10.1021/acsnanomed.6c00124 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano Medicine, online erschienen am 30.09.2026. Verfasst von Jie Min und 7 weiteren Autor:innen. Die Arbeit nennt 200 Literaturangaben. Gefördert von: Basic Research Program of Jiangsu Province, Xi?an Jiaotong-Liverpool University.
Abstract (Originalsprache)
Intracerebral hemorrhage (ICH) is the most fatal form of stroke, affecting several million people each year worldwide. Current clinical treatments for ICH remain far from satisfactory, underscoring a clear need for technological innovation. Specifically, in recent years, nanomaterial-based technologies have emerged as a suite of innovative solutions for ICH. Despite the considerable opportunities demonstrated in these studies, insufficient attention has been paid to the challenges of clinical translation. To bridge the gap between nanotechnologists and neurologists, this review addresses three key aspects. We first discuss the biological aspect: pathophysiology and therapeutic targets of ICH. Second, we review the technological aspect: various applications of nanotechnology in the context of ICH, including nanozymes, drug delivery carriers, nanoparticles in hydrogels, imaging probes, and neural stimulation transducers. Third, we examine the translational aspect: critical issues in clinical translation, particularly toxicology and production scale-up of nanomaterials. Together, this review aims to provide a roadmap for nanotechnologists and neurologists to collaboratively advance ICH nanomedicines from bench to bedside.
Förderung
- Basic Research Program of Jiangsu Province
- Xi?an Jiaotong-Liverpool University
Zitieren
APA
Min, J., Gao, J., Hao, Z., Wu, X., Liptrott, N. J., Yang, J., Chen, Y., & Ruan, G. (2026). Nanotechnology for Intracerebral Hemorrhage: Advances, Opportunities, and Potential for Clinical Translation. ACS Nano Medicine, 1(10), 2540-2568. https://doi.org/10.1021/acsnanomed.6c00124
Vancouver
Min J, Gao J, Hao Z, Wu X, Liptrott NJ, Yang J, et al. Nanotechnology for Intracerebral Hemorrhage: Advances, Opportunities, and Potential for Clinical Translation. ACS Nano Medicine. 2026;1(10):2540-2568. doi:10.1021/acsnanomed.6c00124
BibTeX
@article{Min2026,
author = {Min, Jie and Gao, Jieyi and Hao, Zerun and Wu, Xian and Liptrott, Neill J. and Yang, Jun and Chen, Yizhao and Ruan, Gang},
title = {Nanotechnology for Intracerebral Hemorrhage: Advances, Opportunities, and Potential for Clinical Translation},
journal = {ACS Nano Medicine},
year = {2026},
volume = {1},
number = {10},
pages = {2540--2568},
doi = {10.1021/acsnanomed.6c00124}
}
EUVIMED